Related Experiment Video
Updated: Jan 27, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA
Published on: February 9, 2011
Novel two-chain fatty acid-based lipids for development of vancomycin pH-responsive liposomes against Staphylococcus
Sifiso S Makhathini1, Rahul S Kalhapure1,2, Mahantesh Jadhav1
1Discipline of Pharmaceutical Sciences, College of Health Sciences, University of KwaZulu-Natal , Durban , South Africa.
Abstract:
The development of bacterial resistance against antibiotics is attributed to poor localisation of lethal antibiotic dose at the infection site. This study reports on the synthesis and use of novel two-chain fatty acid-based lipids (FAL) containing amino acid head groups in the formulation of pH-responsive liposomes for the targeted delivery of vancomycin (VAN). The formulated liposomes were characterised for their size, polydispersity index (PDI), surface charge and morphology. The drug-loading capacity, drug release, cell viability, and in vitro and in vivo efficacy of the formulations were investigated. A sustained VAN release profile was observed and in vitro antibacterial studies against S. aureus and MRSA showed superior and prolonged activity over 72 h at both pH 7.4 and 6.0. Enhanced antibacterial activity at pH 6.0 was observed for the DOAPA-VAN-Lipo and DLAPA-VAN-Lipo formulations. Flow cytometry studies indicated a high killing rate of MRSA cells using DOAPA-VN-Lipo (71.98%) and DLAPA-VN-Lipo (73.32%). In vivo studies showed reduced MRSA recovered from mice treated with formulations by four- and two-folds lower than bare VN treated mice, respectively. The targeted delivery of VAN can be improved by novel pH-responsive liposomes from the two-chain (FAL) designed in this study.
Insights
Novel pH-responsive liposomes using fatty acid-based lipids (FAL) effectively deliver vancomycin (VAN) to infection sites. These liposomes enhance antibacterial activity against MRSA, improving targeted antibiotic delivery and combating resistance.
Area of Science:
- Biotechnology
- Materials Science
- Pharmaceutical Sciences
Background:
- Antibiotic resistance is a growing threat, exacerbated by poor drug localization at infection sites.
- Targeted drug delivery systems are crucial for enhancing antibiotic efficacy and overcoming resistance.
Purpose of the Study:
- To synthesize and evaluate novel pH-responsive liposomes for targeted vancomycin delivery.
- To investigate the potential of fatty acid-based lipids (FAL) with amino acid head groups in liposome formulation.
Main Methods:
- Formulation and characterization of pH-responsive liposomes containing vancomycin (VAN).
- Assessment of drug loading, release kinetics, and stability.
- In vitro evaluation of antibacterial activity against S. aureus and MRSA.
- In vivo efficacy studies in a mouse model.
Main Results:
- Liposomes exhibited sustained VAN release and prolonged in vitro antibacterial activity over 72 hours.
- Enhanced efficacy at pH 6.0 was observed for specific liposome formulations (DOAPA-VAN-Lipo, DLAPA-VAN-Lipo).
- High MRSA killing rates (71.98% and 73.32%) and significant reduction in bacterial load in vivo were achieved.
Conclusions:
- Novel pH-responsive liposomes based on FAL show promise for targeted vancomycin delivery.
- These formulations can improve antibiotic localization and efficacy, addressing bacterial resistance.
- The study highlights the potential of tailored liposomal systems in combating challenging infections.
More Related Videos
Related Concept Videos
Structure of Lipids
What are Lipids?
Overview of Fatty Acid Metabolism
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
Responses to Heat and Cold Stress
Lipid Digestion
Development of Antibiotic Resistance

